These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 31418063)

  • 61. Noncarbapenems for the Treatment of Urinary Tract Infections Caused by Extended-Spectrum β-Lactamase-Producing Bacteria.
    White CW; Kyle JA; Deas CM; Campbell J
    South Med J; 2019 Aug; 112(8):438-443. PubMed ID: 31375841
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Treatment of recurrent complicated urinary tract infections in children with vesicoureteral reflux.
    Wu TH; Huang FL; Fu LS; Chou CM; Chien YL; Huang CM; Lin CF; Chen PY
    J Microbiol Immunol Infect; 2016 Oct; 49(5):717-722. PubMed ID: 25442872
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Executive summary of the diagnosis and treatment of urinary tract infection: Guidelines of the Spanish Society of Clinical Microbiology and Infectious Diseases (SEIMC).
    de Cueto M; Aliaga L; Alós JI; Canut A; Los-Arcos I; Martínez JA; Mensa J; Pintado V; Rodriguez-Pardo D; Yuste JR; Pigrau C
    Enferm Infecc Microbiol Clin; 2017 May; 35(5):314-320. PubMed ID: 28017477
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Tigecycline in treatment of multidrug-resistant Gram-negative bacillus urinary tract infections: a systematic review.
    Brust K; Evans A; Plemmons R
    J Antimicrob Chemother; 2014 Oct; 69(10):2606-10. PubMed ID: 24879669
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Extended spectrum beta-lactamase producing multidrug resistant urinary isolates from children visiting Kathmandu Model Hospital.
    Dhakal S; Manandhar S; Shrestha B; Dhakal R; Pudasaini M
    Nepal Med Coll J; 2012 Jun; 14(2):136-41. PubMed ID: 23671965
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Febrile urinary-tract infection due to extended-spectrum beta-lactamase-producing Enterobacteriaceae in children: A French prospective multicenter study.
    Madhi F; Jung C; Timsit S; Levy C; Biscardi S; Lorrot M; Grimprel E; Hees L; Craiu I; Galerne A; Dubos F; Cixous E; Hentgen V; Béchet S; ; Bonacorsi S; Cohen R
    PLoS One; 2018; 13(1):e0190910. PubMed ID: 29370234
    [TBL] [Abstract][Full Text] [Related]  

  • 67. ANTIBIOTIC SUSCEPTIBILITY OF ORGANISMS CAUSING URINARY TRACT INFECTION IN PATIENTS PRESENTING AT KENYATTA NATIONAL HOSPITAL, NAIROBI.
    Magale HI; Kassim IA; Odera SA; Omolo MJ; Jaoko WG; Jolly PE
    East Afr Med J; 2015 Jul; 92(7):333-337. PubMed ID: 27867208
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Emerging resistance problems and future perspectives in pharmacotherapy for complicated urinary tract infections.
    Chen YH; Ko WC; Hsueh PR
    Expert Opin Pharmacother; 2013 Apr; 14(5):587-96. PubMed ID: 23480061
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Extended-spectrum beta-lactamase-producing Enterobacteriaceae in hospital urinary tract infections: incidence and antibiotic susceptibility profile over 9 years.
    Toner L; Papa N; Aliyu SH; Dev H; Lawrentschuk N; Al-Hayek S
    World J Urol; 2016 Jul; 34(7):1031-7. PubMed ID: 26511749
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Comparison of community-onset healthcare-associated and hospital-acquired urinary infections caused by extended-spectrum beta-lactamase-producing Escherichia coli and antimicrobial activities.
    Saltoglu N; Karali R; Yemisen M; Ozaras R; Balkan II; Mete B; Tabak F; Mert A; Hondur N; Ozturk R
    Int J Clin Pract; 2015 Jul; 69(7):766-70. PubMed ID: 25683907
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The antibiotic susceptibility patterns of uropathogens among children with urinary tract infection in Shiraz.
    Pouladfar G; Basiratnia M; Anvarinejad M; Abbasi P; Amirmoezi F; Zare S
    Medicine (Baltimore); 2017 Sep; 96(37):e7834. PubMed ID: 28906365
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Urinary tract infection caused by community-acquired extended-spectrum β-lactamase-producing bacteria in infants.
    Kim YH; Yang EM; Kim CJ
    J Pediatr (Rio J); 2017; 93(3):260-266. PubMed ID: 27842212
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Efficacy of mecillinam against clinical multidrug-resistant Escherichia coli in a murine urinary tract infection model.
    Zykov IN; Frimodt-Møller N; Småbrekke L; Sundsfjord A; Samuelsen Ø
    Int J Antimicrob Agents; 2020 Feb; 55(2):105851. PubMed ID: 31770624
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Detection of TEM and CTX-M genes from ciprofloxacin resistant Proteus mirabilis and Escherichia coli isolated on urinary tract infections (UTIs).
    Rajivgandhi G; Maruthupandy M; Manoharan N
    Microb Pathog; 2018 Aug; 121():123-130. PubMed ID: 29778819
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Urinary tract infections due to extended-spectrum beta-lactamase-producing Gram-negative bacteria: identification of risk factors and outcome predictors in an Australian tertiary referral hospital.
    Osthoff M; McGuinness SL; Wagen AZ; Eisen DP
    Int J Infect Dis; 2015 May; 34():79-83. PubMed ID: 25769526
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Molecular characterization of extended spectrum β -lactamases enterobacteriaceae causing lower urinary tract infection among pediatric population.
    Eltai NO; Al Thani AA; Al-Ansari K; Deshmukh AS; Wehedy E; Al-Hadidi SH; Yassine HM
    Antimicrob Resist Infect Control; 2018; 7():90. PubMed ID: 30069306
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Uropathogen Resistance and Antibiotic Prophylaxis: A Meta-analysis.
    Selekman RE; Shapiro DJ; Boscardin J; Williams G; Craig JC; Brandström P; Pennesi M; Roussey-Kesler G; Hari P; Copp HL
    Pediatrics; 2018 Jul; 142(1):. PubMed ID: 29954832
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Prevalence, antibiotic sensitivity pattern and genetic analysis of extended spectrum beta lactamase producing Escherichia coli and Klebsiella spp among patients with community acquired urinary tract infection in Galle district, Sri Lanka.
    Priyadharshana U; Piyasiri LB; Wijesinghe C
    Ceylon Med J; 2019 Dec; 64(4):140-145. PubMed ID: 32120467
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Prospective cohort study on hospitalised patients with suspected urinary tract infection and risk factors por multidrug resistance.
    Garcia-Bustos V; Escrig AIR; López CC; Estellés RA; Jerusalem K; Cabañero-Navalón MD; Massó VM; Sigona-Giangreco IA; Sahuquillo-Arce JM; Hernández IC; Lletí MS
    Sci Rep; 2021 Jun; 11(1):11927. PubMed ID: 34099754
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Antibiotic resistance in children with recurrent or complicated urinary tract infection.
    Younis N; Quol K; Al-Momani T; Al-Awaisheh F; Al-Kayed D
    JNMA J Nepal Med Assoc; 2009; 48(173):14-9. PubMed ID: 19529052
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.